Related Experiment Video
Updated: Sep 18, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
μ-Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks
Dajung J Kim1, Manyoel Lim1,2, Thiago D Nascimento1,3
1Headache and Orofacial Pain Effort (H.O.P.E.) Laboratory, Department of Biologic and Materials Sciences & Prosthodontics, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Objective:
The possible impact of meningeal μ-opioid receptor (μOR) binding in migraine remains unknown. This study investigated μOR availability in the cranial parameninges involved in migraine initiation via nociceptor activation.
Methods:
We used positron emission tomography with [11C] carfentanil, and measured μOR availability in meninges and adjacent skull bone (parameningeal tissue [PMT]) under resting and sustained thermal pain threshold stress challenge conditions. μOR availability was compared between individuals with migraine in interictal and ictal phases and healthy controls. Furthermore, we examined the relationship between μOR availability and headache intensity, as well as the potential influence of sex on this measure.
Results:
A total of 36 patients with interictal episodic migraine (8 also assessed ictally), 7 patients with ictal chronic migraine, and 22 healthy controls were included in the analysis. Both the episodic migraine and chronic migraine groups showed lower μOR availability in the parietal PMT than healthy controls during the ictal resting phase. No significant differences were observed during the interictal phase. Exploratory analyses on the effects of sex indicated that both healthy women and migraine patients of both sexes showed lower μOR availability in the frontal PMT compared with healthy men in the ictal sustained thermal pain threshold stress condition. Furthermore, the interictal μOR availability in the frontal PMT was negatively associated with headache intensity in the preceding month.
Interpretation:
The observed variability in PMT μOR availability across the different cortical regions and migraine episodes, along with its association with pain intensity, underscores the critical role of extracerebral mechanisms in migraine pathophysiology. ANN NEUROL 2025;98:777-787.
Insights
Migraine patients have lower meningeal μ-opioid receptor (μOR) availability, particularly during ictal phases. This suggests extracerebral mechanisms contribute to migraine pain and are linked to headache intensity.
Area of Science:
- Neuroscience
- Pain Research
- Medical Imaging
Background:
- The role of meningeal μ-opioid receptors (μOR) in migraine pathophysiology is not fully understood.
- Migraine involves nociceptor activation and extracerebral mechanisms.
Purpose of the Study:
- To investigate μOR availability in cranial parameningeal tissue (PMT) in individuals with migraine.
- To compare μOR availability between migraineurs and healthy controls during resting and stress conditions.
Main Methods:
- Positron emission tomography (PET) with [11C] carfentanil was used to measure μOR availability in PMT.
- μOR availability was assessed in episodic migraine (interictal and ictal phases), chronic migraine (ictal phase), and healthy controls.
- Relationships between μOR availability, headache intensity, and sex were examined.
Main Results:
- Individuals with episodic and chronic migraine showed reduced μOR availability in the parietal PMT during ictal phases compared to controls.
- No significant differences were found during interictal phases.
- Lower μOR availability in frontal PMT was observed in women and migraine patients under stress, compared to healthy men. Interictal frontal μOR availability correlated negatively with headache intensity.
Conclusions:
- Variability in PMT μOR availability is linked to migraine episodes and pain intensity.
- Extracerebral mechanisms, involving meningeal μOR, play a significant role in migraine pathophysiology.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Pain

